Timelo Investment Management Inc. Zymeworks Inc. Transaction History

Timelo Investment Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	SELL	$4.65 - $7.43 $2.43 Million - $3.88 Million	-522,575 Reduced 56.38%	404,226 $2.49 Million
Q2 2022 Aug 01, 2022	BUY	$4.82 - $7.7 $2.35 Million - $3.75 Million	487,461 Added 110.95%	926,801 $4.91 Million
Q1 2022 May 10, 2022	BUY	$6.0 - $16.98 $1.22 Million - $3.45 Million	203,442 Added 86.24%	439,340 $2.88 Million
Q4 2021 Feb 10, 2022	BUY	$15.19 - $29.33 $3.58 Million - $6.92 Million	235,898 New	235,898 $3.87 Million

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $949M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of Timelo Investment Management Inc., based on Form 13F filings with the SEC.

Stay updated on Timelo Investment Management Inc. with notifications on news.